The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer

Autores da FMUP

• Raquel Ângela Silva Soares Lino

  Autor

Participantes de fora da FMUP

• Sousa, AP
• Costa, R
• Alves, MG
• Baylina, P
• Fernandes, R

Unidades de investigação

• Biomedicina

Abstract

Abstract no disponible

Keywords

• 3(or 17)beta hydroxysteroid dehydrogenase; androgen receptor; annexin; CD82 antigen; cell adhesion molecule; checkpoint kinase 2; cyclin dependent kinase inhibitor 1B; cyclin dependent kinase inhibitor 2A; cytochrome P450 family 17; epidermal growth factor; epidermal growth factor receptor; glutathione transferase; hepsin; Hermes antigen; homeodomain protein; hydroxymethylglutaryl coenzyme A reductase kinase; insulin; integrin; interleukin 6; kruppel like factor 6; macrophage receptor scavenger 1; nerve growth factor; phosphodiesterase; prostate stem cell antigen; protein kinase Pim 1; protein p53; ribonuclease L; scavenger receptor; sex hormone; somatomedin; STAT5 protein; steroid 5alpha reductase 2; tensin; toll like receptor 4; tyrosine kinase receptor; unclassified drug; uvomorulin; vasculotropin; zinc phosphodiesterase elac protein 2; adipose tissue; age; amino acid metabolism; atrial fibrillation; B cell lymphoma; cancer radiotherapy; cancer screening; cancer susceptibility; chol